| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cholera was largely eliminated from industrialized countries by water and sewage treatment over a century ago. Today it remains a significant cause of morbidity and mortality in developing countries, where it is a marker for inadequate drinking water and sanitation infrastructure. Death from cholera can be prevented through simple treatment—oral, or in severe cases, intravenous rehydration. The cholera case-fatality rate therefore reflects access to basic health care. We reviewed World Health Organization (WHO) data on cholera cases and deaths reported between 1960 and 2005. In the 1960s, at the beginning of the seventh and current cholera pandemic, cholera had an exclusively Asian focus. In 1970, the pandemic reached sub-Saharan Africa, where it has remained entrenched. In 1991, the seventh pandemic reached Latin America, resulting in nearly 1 million reported cases from the region within 3 years. In contrast to the persisting situation in Africa, cholera was largely eliminated from Latin America within a decade. In 2005, 31 (78%) of the 40 countries that reported indigenous cases of cholera to WHO were in sub-Saharan Africa. The reported incidence of indigenous cholera in sub-Saharan Africa in 2005 (166 cases/million population) was 95 times higher than the reported incidence in Asia (1.74 cases/million population) and 16,600 times higher than the reported incidence in Latin America (0.01 cases/million population). In that same year, the cholera case fatality rate in sub-Saharan Africa (1.8%) was 3 times higher than that in Asia (0.6%); no cholera deaths were reported in Latin America. The persistence or control of cholera in Africa will be a key indicator of global efforts to reach the Millennium Development Goals and of recent commitments by leaders of the G-8 countries to increase development aid to the region.
Received May 25, 2007. Accepted for publication July 9, 2007.
Acknowledgments: We thank Mike Hoekstra for guidance with biostatistics issues and Tracy Ayers for help with construction of figures for this manuscript.
* Address correspondence to Nicholas Gaffga, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop A-38, Atlanta, GA 30333. E-mail: ngaffga{at}cdc.gov
Authors’ addresses: Nicholas Gaffga, Robert V. Tauxe, and Eric D. Mintz, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop A-38, Atlanta, GA 30333.
Reprint requests: Nicholas Gaffga, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop A-38, Atlanta, GA 30333. E-mail: ngaffga{at}cdc.gov.
This article has been cited by other articles:
|
|
 |
|
  O-T. Shikanga, D. Mutonga, M. Abade, S. Amwayi, M. Ope, H. Limo, E. D. Mintz, R. E. Quick, R. F. Breiman, and D. R. Feikin High Mortality in a Cholera Outbreak in Western Kenya after Post-Election Violence in 2008 Am J Trop Med Hyg, December 1, 2009; 81(6): 1085 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sasaki, H. Suzuki, Y. Fujino, Y. Kimura, and M. Cheelo Impact of Drainage Networks on Cholera Outbreaks in Lusaka, Zambia Am J Public Health, November 1, 2009; 99(11): 1982 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Mintz and R. L. Guerrant A Lion in Our Village -- The Unconscionable Tragedy of Cholera in Africa N. Engl. J. Med., March 12, 2009; 360(11): 1060 - 1063. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Opintan, M. J. Newman, O. A. Nsiah-Poodoh, and I. N. Okeke Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element J. Antimicrob. Chemother., November 1, 2008; 62(5): 929 - 933. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
